Yousif Capital Management LLC Sells 361 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Yousif Capital Management LLC decreased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 68,597 shares of the company’s stock after selling 361 shares during the period. Yousif Capital Management LLC’s holdings in GE HealthCare Technologies were worth $5,536,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Susquehanna Fundamental Investments LLC purchased a new position in shares of GE HealthCare Technologies during the 4th quarter valued at $20,891,000. Apollon Wealth Management LLC raised its stake in GE HealthCare Technologies by 46.5% in the 4th quarter. Apollon Wealth Management LLC now owns 13,111 shares of the company’s stock valued at $1,025,000 after acquiring an additional 4,160 shares during the period. JPMorgan Chase & Co. lifted its holdings in GE HealthCare Technologies by 29.8% during the third quarter. JPMorgan Chase & Co. now owns 2,233,603 shares of the company’s stock valued at $209,624,000 after purchasing an additional 512,778 shares during the last quarter. Asset Management One Co. Ltd. boosted its position in GE HealthCare Technologies by 5.9% during the fourth quarter. Asset Management One Co. Ltd. now owns 174,412 shares of the company’s stock worth $13,867,000 after purchasing an additional 9,662 shares during the period. Finally, Dark Forest Capital Management LP boosted its position in GE HealthCare Technologies by 154.4% during the fourth quarter. Dark Forest Capital Management LP now owns 7,343 shares of the company’s stock worth $574,000 after purchasing an additional 4,457 shares during the period. 82.06% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts recently commented on GEHC shares. Evercore ISI dropped their price target on shares of GE HealthCare Technologies from $96.00 to $85.00 and set an “outperform” rating on the stock in a research note on Thursday, May 1st. Wall Street Zen raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating in a report on Saturday, May 31st. Wells Fargo & Company cut their price target on GE HealthCare Technologies from $103.00 to $89.00 and set an “overweight” rating for the company in a report on Thursday, May 1st. UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and decreased their price objective for the company from $74.00 to $73.00 in a research note on Monday, May 5th. Finally, Morgan Stanley dropped their price objective on GE HealthCare Technologies from $86.00 to $78.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 6th. Three investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $88.27.

GE HealthCare Technologies Price Performance

NASDAQ:GEHC opened at $73.40 on Thursday. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80. The stock has a fifty day moving average of $68.15 and a 200 day moving average of $78.48. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The firm has a market capitalization of $33.61 billion, a price-to-earnings ratio of 16.95, a P/E/G ratio of 3.19 and a beta of 1.14.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, April 30th. The company reported $1.01 EPS for the quarter, topping the consensus estimate of $0.91 by $0.10. The company had revenue of $4.78 billion during the quarter, compared to analyst estimates of $4.66 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. GE HealthCare Technologies’s revenue was up 2.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.90 earnings per share. On average, research analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Friday, April 25th were issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.19%. The ex-dividend date of this dividend was Friday, April 25th. GE HealthCare Technologies’s payout ratio is 2.95%.

GE HealthCare Technologies declared that its Board of Directors has initiated a stock repurchase program on Wednesday, April 30th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the company to purchase up to 3.1% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board believes its shares are undervalued.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.